

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.89905484 |
| 2 | cytidine metabolic process (GO:0046087) | 5.48744009 |
| 3 | cytidine catabolic process (GO:0006216) | 5.48744009 |
| 4 | cytidine deamination (GO:0009972) | 5.48744009 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.03855615 |
| 6 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.49747430 |
| 7 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.49747430 |
| 8 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.48515389 |
| 9 | behavioral response to nicotine (GO:0035095) | 4.03894315 |
| 10 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.78642469 |
| 11 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.74237703 |
| 12 | protein neddylation (GO:0045116) | 3.70909589 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.68928885 |
| 14 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.62941189 |
| 15 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.61466370 |
| 16 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.59052669 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 3.59052669 |
| 18 | aggressive behavior (GO:0002118) | 3.57374208 |
| 19 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.54658997 |
| 20 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.54658997 |
| 21 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.54658997 |
| 22 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.49463355 |
| 23 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.49463355 |
| 24 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.47008211 |
| 25 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.44699669 |
| 26 | proteasome assembly (GO:0043248) | 3.43875510 |
| 27 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.37889436 |
| 28 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.37889436 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.37272755 |
| 30 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.33592515 |
| 31 | rRNA modification (GO:0000154) | 3.32149936 |
| 32 | S-adenosylmethionine metabolic process (GO:0046500) | 3.30076237 |
| 33 | respiratory chain complex IV assembly (GO:0008535) | 3.29520467 |
| 34 | kynurenine metabolic process (GO:0070189) | 3.25742153 |
| 35 | iron-sulfur cluster assembly (GO:0016226) | 3.21436030 |
| 36 | metallo-sulfur cluster assembly (GO:0031163) | 3.21436030 |
| 37 | negative regulation of ligase activity (GO:0051352) | 3.21204237 |
| 38 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.21204237 |
| 39 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.19759006 |
| 40 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.17827655 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.07839417 |
| 42 | L-fucose catabolic process (GO:0042355) | 3.03674247 |
| 43 | fucose catabolic process (GO:0019317) | 3.03674247 |
| 44 | L-fucose metabolic process (GO:0042354) | 3.03674247 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.99714035 |
| 46 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99347763 |
| 47 | electron transport chain (GO:0022900) | 2.98368378 |
| 48 | tryptophan catabolic process (GO:0006569) | 2.97604639 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.97604639 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.97604639 |
| 51 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.95864614 |
| 52 | cytochrome complex assembly (GO:0017004) | 2.89396394 |
| 53 | respiratory electron transport chain (GO:0022904) | 2.87916976 |
| 54 | negative regulation by host of viral transcription (GO:0043922) | 2.87664550 |
| 55 | rRNA methylation (GO:0031167) | 2.84413600 |
| 56 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.84029656 |
| 57 | tryptophan metabolic process (GO:0006568) | 2.81872346 |
| 58 | GPI anchor metabolic process (GO:0006505) | 2.81195538 |
| 59 | positive regulation of ligase activity (GO:0051351) | 2.79973009 |
| 60 | protein complex biogenesis (GO:0070271) | 2.78909241 |
| 61 | positive regulation of defense response to virus by host (GO:0002230) | 2.77542855 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.76121283 |
| 63 | mannosylation (GO:0097502) | 2.73533289 |
| 64 | positive regulation of cell cycle arrest (GO:0071158) | 2.73083144 |
| 65 | regulation of cellular amine metabolic process (GO:0033238) | 2.73000768 |
| 66 | positive regulation of prostaglandin secretion (GO:0032308) | 2.71777859 |
| 67 | piRNA metabolic process (GO:0034587) | 2.70269468 |
| 68 | GPI anchor biosynthetic process (GO:0006506) | 2.68950899 |
| 69 | response to pheromone (GO:0019236) | 2.68740507 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 2.66944997 |
| 71 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.65224005 |
| 72 | regulation of interleukin-8 secretion (GO:2000482) | 2.64891479 |
| 73 | platelet dense granule organization (GO:0060155) | 2.64397225 |
| 74 | sulfation (GO:0051923) | 2.64301079 |
| 75 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.64109197 |
| 76 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.62035231 |
| 77 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.60606364 |
| 78 | cullin deneddylation (GO:0010388) | 2.58905331 |
| 79 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.57529633 |
| 80 | termination of RNA polymerase III transcription (GO:0006386) | 2.57529633 |
| 81 | B cell mediated immunity (GO:0019724) | 2.55713748 |
| 82 | negative regulation of mast cell activation (GO:0033004) | 2.54596306 |
| 83 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.53437677 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 2.52617316 |
| 85 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.50002656 |
| 86 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.48285387 |
| 87 | protein deneddylation (GO:0000338) | 2.43940603 |
| 88 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.40250758 |
| 89 | positive regulation of fatty acid transport (GO:2000193) | 2.40064157 |
| 90 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.39457773 |
| 91 | tRNA processing (GO:0008033) | 2.39340842 |
| 92 | peptidyl-histidine modification (GO:0018202) | 2.37207464 |
| 93 | pseudouridine synthesis (GO:0001522) | 2.36608231 |
| 94 | negative regulation of T cell apoptotic process (GO:0070233) | 2.35503099 |
| 95 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.34615588 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.33906942 |
| 97 | regulation of cell cycle arrest (GO:0071156) | 2.33680058 |
| 98 | rRNA catabolic process (GO:0016075) | 2.32463680 |
| 99 | proton transport (GO:0015992) | 2.32353930 |
| 100 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.31713523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.27510784 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88596471 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.80598603 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.54533734 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.38609606 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.09556104 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.97854823 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.92235885 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.87910547 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.84140852 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81488377 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.76009427 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.73263152 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46203686 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45828256 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.40370054 |
| 17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.32409977 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.30103390 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.26338888 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.19977658 |
| 21 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19719777 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.15863281 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13490685 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12265088 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09102816 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02092841 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.97559316 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78186942 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78026610 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73256504 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.70362629 |
| 32 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.66146461 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.62457447 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.59433177 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59421945 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52648108 |
| 37 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.49598791 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.49500675 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48100010 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.46798234 |
| 41 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45587209 |
| 42 | AR_20517297_ChIP-Seq_VCAP_Human | 1.45023000 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.41825056 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34551894 |
| 45 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31162898 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31162898 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29049693 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.25585954 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25206762 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24867783 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23976244 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23027202 |
| 53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.22693647 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22474948 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22464705 |
| 56 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22122518 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21349666 |
| 58 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20460581 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.20326302 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19072547 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18245928 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18245928 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17656725 |
| 64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.16031312 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15397359 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13093610 |
| 67 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11823438 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08763126 |
| 69 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07457887 |
| 70 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06452031 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05792989 |
| 72 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.05440318 |
| 73 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.04704351 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04322626 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04322626 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04024805 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03653777 |
| 78 | GATA3_26560356_Chip-Seq_TH1_Human | 1.03358338 |
| 79 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02836479 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02646461 |
| 81 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02490780 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02360559 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00398198 |
| 84 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99726072 |
| 85 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99199980 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98775445 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98638442 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98365325 |
| 89 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98069955 |
| 90 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98020595 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97687555 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96934042 |
| 93 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96766456 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96128738 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95807433 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95512306 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95340942 |
| 98 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95198860 |
| 99 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94420423 |
| 100 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92491538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.60233076 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.50877485 |
| 3 | MP0000372_irregular_coat_pigmentation | 3.02867507 |
| 4 | MP0005084_abnormal_gallbladder_morpholo | 2.91941270 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.82843646 |
| 6 | MP0002102_abnormal_ear_morphology | 2.64987403 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.42518163 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36623266 |
| 9 | MP0008872_abnormal_physiological_respon | 2.33427363 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.31733279 |
| 11 | MP0008058_abnormal_DNA_repair | 2.13643357 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.10653088 |
| 13 | MP0002163_abnormal_gland_morphology | 2.08050621 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 1.93066059 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 1.91457095 |
| 16 | MP0003011_delayed_dark_adaptation | 1.87251882 |
| 17 | MP0009785_altered_susceptibility_to | 1.85116988 |
| 18 | MP0001800_abnormal_humoral_immune | 1.67647774 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 1.65201695 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.64284170 |
| 21 | MP0003866_abnormal_defecation | 1.63799997 |
| 22 | MP0003693_abnormal_embryo_hatching | 1.62083052 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 1.58316452 |
| 24 | MP0004043_abnormal_pH_regulation | 1.57564142 |
| 25 | MP0003880_abnormal_central_pattern | 1.53631304 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.52589200 |
| 27 | MP0006082_CNS_inflammation | 1.51199595 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 1.47454514 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.46437635 |
| 30 | MP0005410_abnormal_fertilization | 1.44133796 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.43988378 |
| 32 | MP0008995_early_reproductive_senescence | 1.43578928 |
| 33 | MP0003195_calcinosis | 1.42041924 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.40365444 |
| 35 | MP0002723_abnormal_immune_serum | 1.39984366 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.39371907 |
| 37 | MP0003718_maternal_effect | 1.39218656 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.36181328 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.33366231 |
| 40 | MP0005253_abnormal_eye_physiology | 1.32262054 |
| 41 | MP0003786_premature_aging | 1.31319810 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.29921003 |
| 43 | MP0005332_abnormal_amino_acid | 1.29236714 |
| 44 | MP0002006_tumorigenesis | 1.28031969 |
| 45 | MP0001819_abnormal_immune_cell | 1.27802704 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.27606198 |
| 47 | MP0003724_increased_susceptibility_to | 1.27303748 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.27136820 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.26367423 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.19143679 |
| 51 | MP0001764_abnormal_homeostasis | 1.18197386 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.17611553 |
| 53 | MP0001790_abnormal_immune_system | 1.16677488 |
| 54 | MP0005387_immune_system_phenotype | 1.16677488 |
| 55 | MP0005025_abnormal_response_to | 1.15162947 |
| 56 | MP0000685_abnormal_immune_system | 1.13592344 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.12018939 |
| 58 | MP0004147_increased_porphyrin_level | 1.09142026 |
| 59 | MP0003646_muscle_fatigue | 1.08610227 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.07754606 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.07530744 |
| 62 | MP0001873_stomach_inflammation | 1.07379815 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.07367469 |
| 64 | MP0005389_reproductive_system_phenotype | 1.06554846 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 1.06401625 |
| 66 | MP0003878_abnormal_ear_physiology | 1.06401625 |
| 67 | MP0008877_abnormal_DNA_methylation | 1.01118375 |
| 68 | MP0005360_urolithiasis | 1.00766840 |
| 69 | MP0002160_abnormal_reproductive_system | 0.99578957 |
| 70 | MP0003763_abnormal_thymus_physiology | 0.98337382 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 0.96119985 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.96003384 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.93955658 |
| 74 | MP0000716_abnormal_immune_system | 0.93295699 |
| 75 | MP0008469_abnormal_protein_level | 0.93284414 |
| 76 | MP0002736_abnormal_nociception_after | 0.93190643 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.92999062 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.89733841 |
| 79 | MP0002398_abnormal_bone_marrow | 0.87851440 |
| 80 | MP0002733_abnormal_thermal_nociception | 0.87380329 |
| 81 | MP0009764_decreased_sensitivity_to | 0.86585149 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.86447116 |
| 83 | MP0001970_abnormal_pain_threshold | 0.85912907 |
| 84 | MP0001905_abnormal_dopamine_level | 0.84759358 |
| 85 | MP0001919_abnormal_reproductive_system | 0.84534355 |
| 86 | MP0010329_abnormal_lipoprotein_level | 0.83857491 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.82328316 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.82311256 |
| 89 | MP0001666_abnormal_nutrient_absorption | 0.80471504 |
| 90 | MP0001929_abnormal_gametogenesis | 0.78188047 |
| 91 | MP0005670_abnormal_white_adipose | 0.75783826 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.75763640 |
| 93 | MP0002272_abnormal_nervous_system | 0.74731519 |
| 94 | MP0009745_abnormal_behavioral_response | 0.74688232 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.74497968 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.74281190 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.73031456 |
| 98 | MP0002429_abnormal_blood_cell | 0.72697174 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.72043601 |
| 100 | MP0002933_joint_inflammation | 0.70331334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoproteinemia (HP:0003075) | 4.07934880 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.67875722 |
| 3 | Mitochondrial inheritance (HP:0001427) | 3.64263759 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.58596318 |
| 5 | Increased CSF lactate (HP:0002490) | 3.57900048 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.52401691 |
| 7 | Abolished electroretinogram (ERG) (HP:0000550) | 3.48662067 |
| 8 | Pancreatic cysts (HP:0001737) | 3.43638122 |
| 9 | Acute encephalopathy (HP:0006846) | 3.34346215 |
| 10 | Hepatic necrosis (HP:0002605) | 3.29440286 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.21363119 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.21363119 |
| 13 | Progressive macrocephaly (HP:0004481) | 3.13781101 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.12428065 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 3.10859190 |
| 16 | Aplastic anemia (HP:0001915) | 3.09525789 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.07749923 |
| 18 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.04814883 |
| 19 | True hermaphroditism (HP:0010459) | 3.01894190 |
| 20 | Abnormality of the prostate (HP:0008775) | 2.96380913 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 2.84088174 |
| 22 | Molar tooth sign on MRI (HP:0002419) | 2.84088174 |
| 23 | Increased serum lactate (HP:0002151) | 2.74767264 |
| 24 | Attenuation of retinal blood vessels (HP:0007843) | 2.73137086 |
| 25 | IgG deficiency (HP:0004315) | 2.72965567 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 2.70305845 |
| 27 | Type 2 muscle fiber atrophy (HP:0003554) | 2.69821700 |
| 28 | Abnormality of alanine metabolism (HP:0010916) | 2.67865693 |
| 29 | Hyperalaninemia (HP:0003348) | 2.67865693 |
| 30 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.67865693 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 2.60465238 |
| 32 | Increased muscle lipid content (HP:0009058) | 2.55054953 |
| 33 | J-shaped sella turcica (HP:0002680) | 2.50701717 |
| 34 | Abnormality of the pons (HP:0007361) | 2.50399253 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.49899642 |
| 36 | Lactic acidosis (HP:0003128) | 2.48497150 |
| 37 | Congenital stationary night blindness (HP:0007642) | 2.46114140 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.46045921 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.42729991 |
| 40 | Carpal bone hypoplasia (HP:0001498) | 2.41885782 |
| 41 | Hypoplasia of the pons (HP:0012110) | 2.40232853 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.36623386 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.36199458 |
| 44 | Decreased central vision (HP:0007663) | 2.35118998 |
| 45 | Cerebral edema (HP:0002181) | 2.34803315 |
| 46 | T lymphocytopenia (HP:0005403) | 2.31869002 |
| 47 | Renal Fanconi syndrome (HP:0001994) | 2.30925031 |
| 48 | Optic disc pallor (HP:0000543) | 2.30420202 |
| 49 | Pendular nystagmus (HP:0012043) | 2.25948521 |
| 50 | Oral leukoplakia (HP:0002745) | 2.25373170 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.23917188 |
| 52 | Muscle fiber atrophy (HP:0100295) | 2.21829707 |
| 53 | Nephronophthisis (HP:0000090) | 2.20275237 |
| 54 | Severe combined immunodeficiency (HP:0004430) | 2.19310439 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.17802998 |
| 56 | Methylmalonic acidemia (HP:0002912) | 2.17089210 |
| 57 | Abnormal biliary tract physiology (HP:0012439) | 2.13911338 |
| 58 | Bile duct proliferation (HP:0001408) | 2.13911338 |
| 59 | Dyschromatopsia (HP:0007641) | 2.07630541 |
| 60 | Renal cortical cysts (HP:0000803) | 2.03942159 |
| 61 | Lethargy (HP:0001254) | 2.03478222 |
| 62 | Cerebral palsy (HP:0100021) | 2.03392798 |
| 63 | Meckel diverticulum (HP:0002245) | 2.03299528 |
| 64 | Respiratory failure (HP:0002878) | 2.02844338 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.02840985 |
| 66 | Abnormality of the ileum (HP:0001549) | 2.01370534 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.99465406 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.99465406 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 1.99465406 |
| 70 | Abnormal glycosylation (HP:0012345) | 1.99465406 |
| 71 | Hypothermia (HP:0002045) | 1.96193489 |
| 72 | Hypoalbuminemia (HP:0003073) | 1.96107152 |
| 73 | Abnormal albumin level (HP:0012116) | 1.96107152 |
| 74 | Opisthotonus (HP:0002179) | 1.95297550 |
| 75 | Thyroiditis (HP:0100646) | 1.95183597 |
| 76 | Abnormality of B cell number (HP:0010975) | 1.95153792 |
| 77 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.94990540 |
| 78 | Hypoplasia of the fovea (HP:0007750) | 1.94990540 |
| 79 | Exertional dyspnea (HP:0002875) | 1.94364630 |
| 80 | Exercise intolerance (HP:0003546) | 1.94305002 |
| 81 | Hyperglycinuria (HP:0003108) | 1.94110771 |
| 82 | Methylmalonic aciduria (HP:0012120) | 1.90143934 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 1.90078832 |
| 84 | Cystic liver disease (HP:0006706) | 1.88876507 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87205379 |
| 86 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83587677 |
| 87 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.83326701 |
| 88 | Abnormality of T cells (HP:0002843) | 1.81320929 |
| 89 | CNS demyelination (HP:0007305) | 1.80914449 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 1.80640173 |
| 91 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80558369 |
| 92 | Increased corneal curvature (HP:0100692) | 1.80179167 |
| 93 | Keratoconus (HP:0000563) | 1.80179167 |
| 94 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.79750931 |
| 95 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78629119 |
| 96 | Stomach cancer (HP:0012126) | 1.78516094 |
| 97 | Sclerocornea (HP:0000647) | 1.76784483 |
| 98 | Abnormality of eosinophils (HP:0001879) | 1.76500404 |
| 99 | Cleft eyelid (HP:0000625) | 1.76365549 |
| 100 | Medial flaring of the eyebrow (HP:0010747) | 1.75602567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 3.40334030 |
| 2 | TAOK3 | 3.38452310 |
| 3 | ZAK | 3.35607052 |
| 4 | TLK1 | 3.26894621 |
| 5 | TXK | 3.17246417 |
| 6 | NUAK1 | 3.09391224 |
| 7 | VRK2 | 3.00980127 |
| 8 | ADRBK2 | 2.79163241 |
| 9 | KDR | 2.40147461 |
| 10 | MST4 | 2.24842955 |
| 11 | STK16 | 2.18016221 |
| 12 | BUB1 | 2.09449609 |
| 13 | VRK1 | 2.08792925 |
| 14 | MUSK | 1.91170179 |
| 15 | GRK1 | 1.85815509 |
| 16 | FRK | 1.71253864 |
| 17 | MAP3K12 | 1.69852322 |
| 18 | PINK1 | 1.67650135 |
| 19 | EIF2AK3 | 1.64192898 |
| 20 | BCKDK | 1.60112580 |
| 21 | TRIM28 | 1.52265438 |
| 22 | DAPK1 | 1.41596605 |
| 23 | ITK | 1.41354313 |
| 24 | KIT | 1.37594899 |
| 25 | SRPK1 | 1.34040699 |
| 26 | TIE1 | 1.25884336 |
| 27 | CDK19 | 1.24475642 |
| 28 | BMPR2 | 1.21122829 |
| 29 | TESK2 | 1.20192910 |
| 30 | WNK4 | 1.11988108 |
| 31 | FES | 1.10942552 |
| 32 | CAMKK2 | 1.08551762 |
| 33 | SYK | 1.08396317 |
| 34 | CSNK1G3 | 1.07492867 |
| 35 | MYLK | 1.03233659 |
| 36 | FLT3 | 0.99250422 |
| 37 | PDK2 | 0.96125346 |
| 38 | TNK2 | 0.95032349 |
| 39 | PLK3 | 0.93180019 |
| 40 | CSNK1A1L | 0.92064746 |
| 41 | BMPR1B | 0.91884231 |
| 42 | OXSR1 | 0.91540185 |
| 43 | CSNK1G1 | 0.90220039 |
| 44 | MAPKAPK3 | 0.89154489 |
| 45 | NME1 | 0.89004121 |
| 46 | CSNK1G2 | 0.86223872 |
| 47 | TSSK6 | 0.86167279 |
| 48 | PHKG2 | 0.84941117 |
| 49 | PHKG1 | 0.84941117 |
| 50 | EPHA4 | 0.84274535 |
| 51 | TEC | 0.83697622 |
| 52 | WNK3 | 0.80744404 |
| 53 | PRKCQ | 0.80117271 |
| 54 | CSF1R | 0.78989039 |
| 55 | TAF1 | 0.78876877 |
| 56 | INSRR | 0.78429368 |
| 57 | MKNK1 | 0.78388984 |
| 58 | IKBKE | 0.77673932 |
| 59 | IKBKB | 0.75589871 |
| 60 | PIK3CG | 0.75275259 |
| 61 | ERBB3 | 0.74952253 |
| 62 | BRSK2 | 0.73314003 |
| 63 | MAPKAPK5 | 0.73311861 |
| 64 | DAPK2 | 0.71314896 |
| 65 | TRPM7 | 0.67085702 |
| 66 | LYN | 0.64572892 |
| 67 | MATK | 0.62071408 |
| 68 | GRK7 | 0.61826689 |
| 69 | MAP4K1 | 0.61444305 |
| 70 | PLK4 | 0.60605671 |
| 71 | PIK3CA | 0.59210729 |
| 72 | JAK3 | 0.57694906 |
| 73 | LCK | 0.56947633 |
| 74 | ADRBK1 | 0.56920376 |
| 75 | MAPK13 | 0.56335985 |
| 76 | CDK8 | 0.56302639 |
| 77 | RPS6KA5 | 0.55444332 |
| 78 | IRAK2 | 0.55306849 |
| 79 | MAP2K6 | 0.55273311 |
| 80 | BLK | 0.55160562 |
| 81 | ATR | 0.54787645 |
| 82 | MAP3K5 | 0.54628904 |
| 83 | RIPK4 | 0.53921590 |
| 84 | MAP3K4 | 0.52001697 |
| 85 | AURKB | 0.49642260 |
| 86 | BTK | 0.49534710 |
| 87 | SCYL2 | 0.48407403 |
| 88 | PLK2 | 0.47521155 |
| 89 | TBK1 | 0.47107827 |
| 90 | PLK1 | 0.45583534 |
| 91 | DYRK2 | 0.43285080 |
| 92 | DAPK3 | 0.41226059 |
| 93 | CSNK1A1 | 0.38859948 |
| 94 | EIF2AK2 | 0.37841104 |
| 95 | IGF1R | 0.37736520 |
| 96 | CSNK2A1 | 0.35658183 |
| 97 | OBSCN | 0.35495367 |
| 98 | PRKCE | 0.35127877 |
| 99 | GRK5 | 0.34464062 |
| 100 | BCR | 0.32215777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.27911455 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.49841154 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.37528672 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.35805880 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.33727111 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.84797439 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72503992 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.43735113 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23077095 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04507310 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02670242 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.90037006 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89018607 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86393830 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.84306938 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.77324704 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.73833422 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68105122 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.58406676 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.53344701 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47208976 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.45922208 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36886067 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.34775125 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.32292829 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31797488 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31585169 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.27966340 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27076739 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.23463260 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15082429 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10766302 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09813597 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09585907 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09062531 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.08217373 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.07378456 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05706942 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.04865821 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04398165 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01425994 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01343694 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99361245 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97200045 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97001528 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94931264 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92463231 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92431010 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92344329 |
| 50 | RNA transport_Homo sapiens_hsa03013 | 0.86442649 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85885933 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85186117 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83063802 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82263137 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81795871 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 0.80205477 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79262130 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79108994 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76573896 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75114805 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.73243729 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72682891 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72058869 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72058311 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71980762 |
| 66 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71171190 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70450559 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68704574 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67148017 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66842216 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65251323 |
| 72 | Spliceosome_Homo sapiens_hsa03040 | 0.65155169 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63745822 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63588900 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61653643 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61298185 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57924359 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56483702 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56475893 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56102697 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54182855 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47811556 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47434621 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46902013 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44666516 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43772418 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43218772 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42917360 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42883413 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42691684 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40409495 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36785555 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35863028 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35417914 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31463390 |
| 96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.29283379 |
| 97 | Taste transduction_Homo sapiens_hsa04742 | 0.27853357 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.27757743 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24908260 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22553616 |

